Bp Wealth Management »

Halozyme Therapeutics shares owned by Bp Wealth Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Bp Wealth Management from 13F filings

Historical chart of Bp Wealth Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Bp Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Bp Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $404k 5.2k 78.27
2025-03-31 $33k 510 63.81

More positions owned by Bp Wealth Management

Apple (AAPL)
iShares Russell Top 200 Growth Etf (IWY)
Ishares Trust Core Msci Eafe E Etf (IEFA)
Microsoft Corporation (MSFT)
iShares Russell Top 200 Value Etf (IWX)
NVIDIA Corporation (NVDA)
Ishares Russell Mid-cap Value Etf (IWS)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Etf (IVV)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Ishares Trust Core Us Aggbd Et Etf (AGG)
JPMorgan Chase & Co. (JPM)
Vanguard Core Bond ETF Etf (VCRB)
Ishares Tr Rus Md Cp Gr Etf Etf (IWP)

View all positions for Bp Wealth Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Alliancebernstein

View all funds holding Halozyme Therapeutics